期刊文献+

异丙托溴铵联合沙丁胺醇治疗慢性阻塞性肺疾病的临床分析

下载PDF
导出
摘要 目的分析异丙托溴铵联合沙丁胺醇治疗慢性阻塞性肺疾病的临床效果。方法选取110例慢性阻塞性肺疾病患者,将其随机分为观察组与对照组,每组55例。观察组给予异丙托溴铵联合沙丁胺醇治疗,对照组单独给予沙丁胺醇治疗,比较两组治疗效果。结果观察组总有效率显著高于对照组(P<0.05);治疗前两组患者FEV1%(第1秒用力呼气容积占预计值百分比)与FEV1/FVC(第1秒用力呼气容积/用力肺活量百分比)比较,无明显差异(P>0.05);治疗后,观察组FEV1%、FEV1/FVC等方面均优于对照组(P<0.05);且治疗后,观察组呼呼吸困难评分明显低于对照组(P<0.05)。结论异丙托溴铵联合沙丁胺醇治疗慢性阻塞性肺疾病的临床效果显著,值得在临床上推广。
作者 官宇男
出处 《中国医药指南》 2016年第17期161-162,共2页 Guide of China Medicine
  • 相关文献

二级参考文献48

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 2Rabe KF,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,managememt,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(10):532-555.
  • 3Combive NT.Inhalaion Aerosol Study Group.In chronic obstructive pulmonary disease,a combination of ipratropium and blbuterol is more effictive than either agent alone.An 85-day multicenter trial[J].Chest,1994,105(12):1 411-1 419.
  • 4Combie NT.Inhalation Solution Study Group.Routine nebulized ipratropium and albuterol together are better than either alone in COPD[J].The Chest,1997,112(6):1 514-1 521.
  • 5Hanania NA,Donohue JF.Pharmacologic interventions in chronic obstructive pulmonary diseade:bronchodilators[J].Proc Am Thorac Soc,2007,4(9):526-534.
  • 6GOLD Executive Committee Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease Revised. 2011 :www. Glodcopd. com.
  • 7Wilkonson TM, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2004, 169(12) : 1298 - 1303.
  • 8Kurashima K, Hara K, Yoned K, et al. Changes in lung function and health status in patient with COPD treated with tiotropium or salmeterol plus fluticasone [ J ]. Respirology, 2009,14 ( 2 ) : 239 - 244.
  • 9Mahler DA,Weels CK. Evaluation of clinical methods for rating dyspnea[ J]. Chest, 1988,93 ( 3 ) :580 - 586.
  • 10Maltais F, Ostinelh J, Bourbeau J, et al. Comparison of nebuliz- ed budesonide and oral prednisolone with placebo in the treat-ment of acute exacerbations of chronic obstructive puhnonary disease[J]. Am J Respir Crit Care Med,2002,165(5):698 -703.

共引文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部